Related references
Note: Only part of the references are listed.Vaccines in Children Exposed to Biological Agents In Utero and/or During Breastfeeding: Are They Effective and Safe?
Javier P. Gisbert et al.
JOURNAL OF CROHNS & COLITIS (2023)
British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids
Mark D. Russell et al.
RHEUMATOLOGY (2023)
A systematic review of live vaccine outcomes in infants exposed to biologic disease modifying anti-rheumatic drugs in utero
Bethan Goulden et al.
RHEUMATOLOGY (2022)
Safety of Live-Attenuated Vaccines in Children Exposed to Biologic Response Modifiers in Utero
Ousseny Zerbo et al.
PEDIATRICS (2022)
Newborn screening for severe combined immunodeficiency: The results of the first pilot TREC and KREC study in Ukraine with involving of 10,350 neonates
Oksana Boyarchuk et al.
FRONTIERS IN IMMUNOLOGY (2022)
Health outcomes of 1000 children born to mothers with inflammatory bowel disease in their first 5 years of life
Shannon Linda Kanis et al.
GUT (2021)
Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)—Part 1: Live Vaccines
Eric I Benchimol et al.
Journal of the Canadian Association of Gastroenterology (2021)
Pregnancy and Neonatal Outcomes After Fetal Exposure to Biologics and Thiopurines Among Women With Inflammatory Bowel Disease
Uma Mahadevan et al.
GASTROENTEROLOGY (2021)
The use and impact of monoclonal antibody biologics during pregnancy
Anne Pham-Huy et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2021)
Safety of Omalizumab During Pregnancy and Breast-Feeding With Assessment of Placental Transfer: A Case Report
Doriane Majou et al.
ALLERGY ASTHMA & IMMUNOLOGY RESEARCH (2021)
In utero exposure to biologic disease-modifying anti-rheumatic drugs and effects to the infant: infectious complications, vaccine response, and safety of live vaccine administration
Angela Berkhout et al.
EXPERT REVIEW OF VACCINES (2019)
British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults
Christopher Andrew Lamb et al.
GUT (2019)
Extended immunophenotyping reference values in a healthy pediatric population
Marina Garcia-Prat et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2019)
From mother to baby: antenatal exposure to monoclonal antibody biologics
Anne Pham-Huy et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2019)
Use of Biologic Therapy by Pregnant Women With Inflammatory Bowel Disease Does Not Affect Infant Response to Vaccines
Dawn B. Beaulieu et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)
Hepatitis B Vaccination Effective in Children Exposed to Anti-Tumour Necrosis Factor Alpha in Utero
Alison de Lima et al.
JOURNAL OF CROHNS & COLITIS (2018)
Lack of placental transfer of certolizumab pegol during pregnancy: results from CRIB, a prospective, postmarketing, pharmacokinetic study
Xavier Mariette et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy
Geoffrey C. Nguyen et al.
GASTROENTEROLOGY (2016)
Alterations in immune function with biologic therapies for autoimmune disease
Minyoung Her et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Biologic therapies and pregnancy: the story so far
Kimme L. Hyrich et al.
RHEUMATOLOGY (2014)
Case Report: Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's Disease
Kuldeep Cheent et al.
JOURNAL OF CROHNS & COLITIS (2010)
Rituximab administration in third trimester of pregnancy suppresses neonatal B-cell development
D. T. Klink et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2008)
Share Paper
